While Doxil itself had negligible effect on the expression of c-Myc, cyclin D1, or survivin, sFZD7 alone or in combination with Doxil decreased the tumor levels of these three downstream target proteins of Wnt/β-catenin signaling. Here, BIRC5 is linked to neoplasm.